DK0617959T3 - Lægemiddel til behandling af hudsygdomme - Google Patents
Lægemiddel til behandling af hudsygdommeInfo
- Publication number
- DK0617959T3 DK0617959T3 DK94104678T DK94104678T DK0617959T3 DK 0617959 T3 DK0617959 T3 DK 0617959T3 DK 94104678 T DK94104678 T DK 94104678T DK 94104678 T DK94104678 T DK 94104678T DK 0617959 T3 DK0617959 T3 DK 0617959T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- medication
- skin diseases
- compound
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4122393A | 1993-03-31 | 1993-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0617959T3 true DK0617959T3 (da) | 2000-01-24 |
Family
ID=21915403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94104678T DK0617959T3 (da) | 1993-03-31 | 1994-03-24 | Lægemiddel til behandling af hudsygdomme |
Country Status (17)
Country | Link |
---|---|
US (1) | US5504084A (da) |
EP (1) | EP0617959B1 (da) |
JP (1) | JP2930281B2 (da) |
KR (1) | KR100310665B1 (da) |
AT (1) | ATE183088T1 (da) |
AU (1) | AU670491B2 (da) |
CA (1) | CA2120319C (da) |
CY (1) | CY2207B1 (da) |
DE (1) | DE69419954T2 (da) |
DK (1) | DK0617959T3 (da) |
ES (1) | ES2135500T3 (da) |
GR (1) | GR3031264T3 (da) |
HU (1) | HU216194B (da) |
IL (1) | IL109151A (da) |
RU (1) | RU2151597C1 (da) |
TW (1) | TW314467B (da) |
ZA (1) | ZA942257B (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2202904C (en) * | 1994-10-17 | 2006-12-19 | Yukio Amano | Pharmaceutical composition for prophylaxis and treatment of type i allergic diseases |
DE19547648A1 (de) * | 1995-12-20 | 1997-06-26 | Hoechst Ag | Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate |
US6011051A (en) * | 1996-07-31 | 2000-01-04 | Hoechst Aktiengesellschaft | Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
EP0987256B1 (de) * | 1997-08-08 | 2001-10-17 | Aventis Pharma Deutschland GmbH | Kristallform von N-(4-Trifluormethylphenyl)-5-methylisoxazol-4-carbonsäureamid |
WO2002080897A1 (en) | 2001-04-05 | 2002-10-17 | Aventis Pharmaceuticals Inc. | Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
WO2005011669A1 (ja) * | 2003-08-05 | 2005-02-10 | Dainippon Sumitomo Pharma Co., Ltd. | 経皮投与用医薬組成物 |
US20050158371A1 (en) * | 2002-02-12 | 2005-07-21 | Sumitomo Pharmaceuticals Co., Ltd. | Novel external agent |
WO2006115509A2 (en) | 2004-06-24 | 2006-11-02 | Novartis Vaccines And Diagnostics Inc. | Small molecule immunopotentiators and assays for their detection |
WO2006082834A1 (ja) * | 2005-02-02 | 2006-08-10 | Kowa Co., Ltd. | ケラチノサイト増殖に起因する疾患の予防・治療剤 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL186239B (nl) * | 1975-06-05 | Hoechst Ag | Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze. | |
DE2854439A1 (de) * | 1978-12-16 | 1980-07-03 | Hoechst Ag | Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung |
DE3035670A1 (de) * | 1980-09-22 | 1982-04-29 | Siemens AG, 1000 Berlin und 8000 München | Vorrichtung zur infusion von fluessigkeiten in den menschlichen oder tierischen koerper |
US5268382A (en) * | 1985-09-27 | 1993-12-07 | Hoechst Aktiengesellschaft | Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus |
DE3534440A1 (de) * | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
GB8619432D0 (en) * | 1986-08-08 | 1986-09-17 | Lilly Industries Ltd | Pharmaceutical compounds |
DE3927257A1 (de) * | 1989-08-18 | 1991-02-21 | Hoechst Ag | Verfahren zur herstellung eines polyolefins |
DD297328A5 (de) * | 1989-08-18 | 1992-01-09 | �������@���������k���Kk�� | 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen |
US5001124A (en) * | 1990-02-02 | 1991-03-19 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
KR100188801B1 (ko) * | 1990-05-18 | 1999-06-01 | 엥겔하르트 라피체 | 이속사졸-4카복스아미드 및 하이드록시알킬리덴 시아노아세트아미드 및 이들 화합물을 함유하는 약제학적 조성물 |
IL99811A (en) * | 1990-10-30 | 1996-03-31 | Roussel Uclaf | 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them |
DE4227594A1 (de) * | 1992-08-20 | 1994-02-24 | Wacker Chemie Gmbh | Synthetische Alumosilikate und ihre Verwendung als heterogene Äquilibrierungskatalysatoren |
-
1994
- 1994-03-14 TW TW083102166A patent/TW314467B/zh not_active IP Right Cessation
- 1994-03-23 US US08/216,332 patent/US5504084A/en not_active Expired - Lifetime
- 1994-03-24 AT AT94104678T patent/ATE183088T1/de active
- 1994-03-24 EP EP94104678A patent/EP0617959B1/en not_active Expired - Lifetime
- 1994-03-24 DK DK94104678T patent/DK0617959T3/da active
- 1994-03-24 ES ES94104678T patent/ES2135500T3/es not_active Expired - Lifetime
- 1994-03-24 DE DE69419954T patent/DE69419954T2/de not_active Expired - Lifetime
- 1994-03-29 AU AU59157/94A patent/AU670491B2/en not_active Expired
- 1994-03-29 IL IL10915194A patent/IL109151A/en not_active IP Right Cessation
- 1994-03-29 KR KR1019940006325A patent/KR100310665B1/ko not_active IP Right Cessation
- 1994-03-30 CA CA002120319A patent/CA2120319C/en not_active Expired - Fee Related
- 1994-03-30 ZA ZA942257A patent/ZA942257B/xx unknown
- 1994-03-30 HU HU9400908A patent/HU216194B/hu unknown
- 1994-03-30 RU RU94011321/14A patent/RU2151597C1/ru active
- 1994-03-30 JP JP6060374A patent/JP2930281B2/ja not_active Expired - Lifetime
-
1999
- 1999-09-22 GR GR990402362T patent/GR3031264T3/el unknown
-
2000
- 2000-12-01 CY CY0000063A patent/CY2207B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR940021060A (ko) | 1994-10-17 |
JP2930281B2 (ja) | 1999-08-03 |
AU5915794A (en) | 1994-10-06 |
CY2207B1 (en) | 2002-11-08 |
GR3031264T3 (en) | 1999-12-31 |
TW314467B (da) | 1997-09-01 |
CA2120319C (en) | 2009-01-06 |
HUT70757A (en) | 1995-10-30 |
IL109151A (en) | 1998-12-27 |
HU216194B (hu) | 1999-05-28 |
ZA942257B (en) | 1994-11-16 |
IL109151A0 (en) | 1994-06-24 |
JPH06329538A (ja) | 1994-11-29 |
EP0617959A1 (en) | 1994-10-05 |
DE69419954T2 (de) | 2000-04-13 |
AU670491C (en) | 1994-10-06 |
ATE183088T1 (de) | 1999-08-15 |
HU9400908D0 (en) | 1994-06-28 |
EP0617959B1 (en) | 1999-08-11 |
ES2135500T3 (es) | 1999-11-01 |
DE69419954D1 (de) | 1999-09-16 |
KR100310665B1 (ko) | 2001-12-28 |
AU670491B2 (en) | 1996-07-18 |
US5504084A (en) | 1996-04-02 |
CA2120319A1 (en) | 1994-10-01 |
RU2151597C1 (ru) | 2000-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2093361T3 (es) | Tratamiento de enfermedades neurodegenerativas. | |
HU9600834D0 (en) | Quinazoline derivatives | |
NO870241D0 (no) | Hypoglykemiske tiazolidindioner. | |
DK0565549T3 (da) | Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B | |
DK0665013T3 (da) | Behandling af hyperproliferative karsygdomme | |
HU910681D0 (en) | Medical solution | |
DE69130586T2 (de) | Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten | |
ES2089136T3 (es) | Tratamiento de enfermedades inflamatorias con la ayuda de derivados 15-ceto-prostaglandinas. | |
DE69707372D1 (de) | Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne | |
DK0617959T3 (da) | Lægemiddel til behandling af hudsygdomme | |
PT98773A (pt) | Processo para a preparacao de di-hidropirido/4,3-d/pirimidinas substituidas na posicao 4 e de composicoes farmaceuticas analgesicas e antiinflamatorias que as contem | |
DK0454429T3 (da) | Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme | |
DK0784973T3 (da) | Quinoxalinderivater til behandling af tinnitus | |
NO995132D0 (no) | Fremgangsmåte for reduksjon av fibrinogen | |
FI941850A0 (fi) | Uusi yhdiste, joka on leustroduksiini H, sen valmistus ja terapeuttinen käyttö | |
DK653687A (da) | Middel til behandling af nyresygdomme | |
ATE159253T1 (de) | 2-thiazolylpyrroleakrylate mit fungizider wirkung |